Price Target Changed • 16h
Price target increased by 16% to ج.م36.78 Up from ج.م31.83, the current price target is an average from 4 analysts. New target price is 15% below last closing price of ج.م43.50. Stock is up 57% over the past year. The company is forecast to post earnings per share of ج.م6.00 for next year compared to ج.م3.94 last year. Board Change • 16h
No independent directors There are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 11 non-independent directors. Director Hussein Mohamed Abdel Salam Badawi was the last director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Duyuru • Mar 13
Misr Fertilizer Production Company, Annual General Meeting, Apr 06, 2026 Misr Fertilizer Production Company, Annual General Meeting, Apr 06, 2026, at 15:30 Egypt Standard Time. Location: cairo Egypt Reported Earnings • May 17
First quarter 2025 earnings released: EPS: ج.م1.35 (vs ج.م3.68 in 1Q 2024) First quarter 2025 results: EPS: ج.م1.35 (down from ج.م3.68 in 1Q 2024). Revenue: ج.م6.34b (up 32% from 1Q 2024). Net income: ج.م2.81b (down 63% from 1Q 2024). Profit margin: 44% (down from 159% in 1Q 2024). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Chemicals industry in Africa. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Board Change • May 14
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 9 non-independent directors. Director Yasser El-Din was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • Mar 24
Misr Fertilizer Production Company, Annual General Meeting, Apr 12, 2025 Misr Fertilizer Production Company, Annual General Meeting, Apr 12, 2025, at 12:00 Egypt Standard Time. Location: cairo Egypt New Risk • Oct 08
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. High level of non-cash earnings (32% accrual ratio). Minor Risk Dividend is not well covered by cash flows (236% cash payout ratio). Reported Earnings • May 27
First quarter 2024 earnings released: EPS: ج.م3.68 (vs ج.م1.18 in 1Q 2023) First quarter 2024 results: EPS: ج.م3.68 (up from ج.م1.18 in 1Q 2023). Revenue: ج.م4.80b (down 5.7% from 1Q 2023). Net income: ج.م7.65b (up 212% from 1Q 2023). Revenue is forecast to grow 21% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 82% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • May 19
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to ج.م51.82, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 640% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م23.36 per share. New Risk • May 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (193% cash payout ratio). Share price has been volatile over the past 3 months (11% average weekly change). Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ج.م47.37, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 643% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م20.64 per share. Upcoming Dividend • Mar 27
Upcoming dividend of ج.م2.00 per share Eligible shareholders must have bought the stock before 03 April 2024. Payment date: 07 April 2024. Payout ratio is a comfortable 46% but the company is paying out more than the cash it is generating. Trailing yield: 3.1%. Lower than top quartile of Egyptian dividend payers (6.3%). Lower than average of industry peers (4.9%). Valuation Update With 7 Day Price Move • Mar 18
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to ج.م48.30, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 688% over the past three years. Valuation Update With 7 Day Price Move • Feb 28
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ج.م62.13, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 835% over the past three years. Reported Earnings • Feb 20
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: ج.م2.87 (down from ج.م31.67 in FY 2022). Revenue: ج.م5.96b (down 68% from FY 2022). Net income: ج.م5.97b (down 18% from FY 2022). Revenue missed analyst estimates by 67%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jan 22
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to ج.م85.03, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 54% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م132 per share. New Risk • Jan 08
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 8x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (29% average weekly change). Shareholders have been substantially diluted in the past year (over 8x increase in shares outstanding). Minor Risk Dividend is not well covered by cash flows (394% cash payout ratio). Buying Opportunity • Dec 28
Now 92% undervalued after recent price drop Over the last 90 days, the stock is down 97%. The fair value is estimated to be ج.م122, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 40% over the last 3 years. Earnings per share has grown by 43%. For the next 3 years, revenue is forecast to grow by 8.1% per annum. Earnings is also forecast to grow by 2.4% per annum over the same time period. Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ج.م446, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 860% over the past three years. Reported Earnings • Dec 02
Third quarter 2023 earnings released: EPS: ج.م5.47 (vs ج.م5.78 in 3Q 2022) Third quarter 2023 results: EPS: ج.م5.47 (down from ج.م5.78 in 3Q 2022). Revenue: ج.م3.82b (up 5.3% from 3Q 2022). Net income: ج.م1.25b (down 5.5% from 3Q 2022). Profit margin: 33% (down from 37% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 120% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Nov 29
Price target increased by 15% to ج.م285 Up from ج.م248, the current price target is an average from 7 analysts. New target price is 47% below last closing price of ج.م540. Stock is up 307% over the past year. The company is forecast to post earnings per share of ج.م31.76 for next year compared to ج.م31.67 last year. Valuation Update With 7 Day Price Move • Oct 31
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ج.م550, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 9x in the Chemicals industry in Egypt. Total returns to shareholders of 1,362% over the past three years. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ج.م377, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 918% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م189 per share. Price Target Changed • Oct 10
Price target increased by 7.5% to ج.م248 Up from ج.م231, the current price target is an average from 7 analysts. New target price is 23% below last closing price of ج.م321. Stock is up 195% over the past year. The company is forecast to post earnings per share of ج.م31.99 for next year compared to ج.م31.67 last year. Valuation Update With 7 Day Price Move • Sep 19
Investor sentiment improves as stock rises 33% After last week's 33% share price gain to ج.م333, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 7x in the Chemicals industry in Egypt. Total returns to shareholders of 756% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م202 per share. Price Target Changed • Sep 13
Price target increased by 12% to ج.م247 Up from ج.م221, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of ج.م251. Stock is up 136% over the past year. The company is forecast to post earnings per share of ج.م30.39 for next year compared to ج.م31.67 last year. Reported Earnings • Aug 31
Second quarter 2023 earnings released: EPS: ج.م6.63 (vs ج.م7.18 in 2Q 2022) Second quarter 2023 results: EPS: ج.م6.63 (down from ج.م7.18 in 2Q 2022). Revenue: ج.م4.33b (down 3.7% from 2Q 2022). Net income: ج.م1.52b (down 7.7% from 2Q 2022). Profit margin: 35% (down from 37% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth. Price Target Changed • Jul 31
Price target increased by 7.7% to ج.م227 Up from ج.م211, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of ج.م230. Stock is up 131% over the past year. The company is forecast to post earnings per share of ج.م29.19 for next year compared to ج.م31.67 last year. Valuation Update With 7 Day Price Move • Jul 09
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ج.م190, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 410% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م151 per share. Price Target Changed • Jun 29
Price target increased by 8.4% to ج.م195 Up from ج.م180, the current price target is an average from 5 analysts. New target price is 16% below last closing price of ج.م232. Stock is up 146% over the past year. The company is forecast to post earnings per share of ج.م25.57 for next year compared to ج.م31.67 last year. New Risk • Jun 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 6.2% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change). Valuation Update With 7 Day Price Move • Jun 13
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to ج.م205, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 596% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م148 per share. Reported Earnings • May 27
First quarter 2023 earnings released: EPS: ج.م17.14 (vs ج.م20.31 in 1Q 2022) First quarter 2023 results: EPS: ج.م17.14 (down from ج.م20.31 in 1Q 2022). Revenue: ج.م1.50b (down 64% from 1Q 2022). Net income: ج.م3.93b (down 16% from 1Q 2022). Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Egypt. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • May 03
Upcoming dividend of ج.م15.00 per share at 8.6% yield Eligible shareholders must have bought the stock before 10 May 2023. Payment date: 14 May 2023. Trailing yield: 8.6%. Within top quartile of Egyptian dividend payers (8.1%). Higher than average of industry peers (6.8%). Price Target Changed • Apr 03
Price target increased by 7.5% to ج.م187 Up from ج.م174, the current price target is an average from 5 analysts. New target price is 18% above last closing price of ج.م158. Stock is up 49% over the past year. The company is forecast to post earnings per share of ج.م29.41 for next year compared to ج.م20.91 last year. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ج.م160, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Egypt. Total returns to shareholders of 394% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م124 per share. Price Target Changed • Mar 06
Price target increased by 12% to ج.م174 Up from ج.م155, the current price target is an average from 5 analysts. New target price is 20% above last closing price of ج.م145. Stock is up 60% over the past year. The company is forecast to post earnings per share of ج.م29.41 for next year compared to ج.م20.91 last year. Price Target Changed • Dec 01
Price target increased to ج.م145 Up from ج.م132, the current price target is an average from 4 analysts. New target price is 9.1% above last closing price of ج.م133. Stock is up 41% over the past year. The company is forecast to post earnings per share of ج.م29.33 for next year compared to ج.م20.91 last year. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 12 non-independent directors. Director Hesham Mohamed El Din was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 18
Second quarter 2022 earnings released: EPS: ج.م7.18 (vs ج.م6.04 in 2Q 2021) Second quarter 2022 results: EPS: ج.م7.18 (up from ج.م6.04 in 2Q 2021). Revenue: ج.م4.50b (up 106% from 2Q 2021). Net income: ج.م1.65b (up 19% from 2Q 2021). Profit margin: 37% (down from 63% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to decline by 5.6% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Egypt are expected to remain flat. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Price Target Changed • Jun 22
Price target increased to ج.م139 Up from ج.م125, the current price target is an average from 3 analysts. New target price is 39% above last closing price of ج.م99.60. Stock is up 32% over the past year. The company is forecast to post earnings per share of ج.م28.39 for next year compared to ج.م20.91 last year. Valuation Update With 7 Day Price Move • May 01
Investor sentiment improved over the past week After last week's 15% share price gain to ج.م110, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 6x in the Chemicals industry in Egypt. Total returns to shareholders of 99% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ج.م172 per share. Price Target Changed • Apr 27
Price target increased to ج.م125 Up from ج.م112, the current price target is an average from 4 analysts. New target price is 26% above last closing price of ج.م98.98. Stock is up 37% over the past year. The company is forecast to post earnings per share of ج.م30.05 for next year compared to ج.م20.91 last year. Board Change • Apr 27
No independent directors There are 5 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: No independent directors. 12 non-independent directors. Director Hesham Mohamed El Din was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Upcoming Dividend • Mar 31
Inaugural dividend of ج.م7.00 per share Eligible shareholders must have bought the stock before 07 April 2022. Payment date: 10 April 2022. The company is not currently making a profit but it is cash flow positive. The company last paid an ordinary dividend in April 2017. The average dividend yield among industry peers is 4.6%. Buying Opportunity • Mar 23
Now 20% undervalued Over the last 90 days, the stock is up 17%. The fair value is estimated to be ج.م134, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 13% per annum over the last 3 years. Major Estimate Revision • Mar 18
Consensus revenue estimates increase by 39% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from ج.م12.3b to ج.م17.1b. EPS estimate increased from ج.م20.01 to ج.م27.90 per share. Net income forecast to grow 51% next year vs 21% growth forecast for Chemicals industry in Egypt. Consensus price target up from ج.م112 to ج.م121. Share price rose 13% to ج.م102 over the past week. Price Target Changed • Mar 15
Price target increased to ج.م121 Up from ج.م112, the current price target is an average from 4 analysts. New target price is 32% above last closing price of ج.م91.21. Stock is up 20% over the past year. The company is forecast to post earnings per share of ج.م21.05 for next year compared to ج.م10.86 last year. Buying Opportunity • Feb 21
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 8.4%. The fair value is estimated to be ج.م107, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years. Buying Opportunity • Jan 21
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 9.6%. The fair value is estimated to be ج.م113, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years. Price Target Changed • Oct 19
Price target increased to ج.م111 Up from ج.م103, the current price target is an average from 5 analysts. New target price is 16% above last closing price of ج.م95.13. Stock is up 104% over the past year. The company is forecast to post earnings per share of ج.م15.08 for next year compared to ج.م10.86 last year. Price Target Changed • Aug 26
Price target increased to ج.م103 Up from ج.م96.12, the current price target is an average from 5 analysts. New target price is 26% above last closing price of ج.م82.18. Stock is up 60% over the past year. Reported Earnings • Jun 20
First quarter 2021 earnings released: EPS ج.م3.46 (vs ج.م2.33 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: ج.م2.00b (up 11% from 1Q 2020). Net income: ج.م792.7m (up 49% from 1Q 2020). Profit margin: 40% (up from 30% in 1Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Major Estimate Revision • Jun 18
Consensus EPS estimates increase to ج.م14.51 The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from ج.م8.65b to ج.م9.34b. EPS estimate increased from ج.م11.28 to ج.م14.51 per share. Net income forecast to grow 3.9% next year vs 3.9% growth forecast for Chemicals industry in Egypt. Consensus price target up from ج.م96.12 to ج.م102. Share price was steady at ج.م75.66 over the past week. Upcoming Dividend • Apr 19
Inaugural dividend of ج.م3.50 per share Eligible shareholders must have bought the stock before 26 April 2021. Payment date: 28 April 2021. The company last paid an ordinary dividend in May 2019. The average dividend yield among industry peers is 5.9%. Is New 90 Day High Low • Feb 17
New 90-day high: ج.م79.28 The company is up 63% from its price of ج.م48.64 on 19 November 2020. The Egyptian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م83.31 per share. Is New 90 Day High Low • Jan 26
New 90-day high: ج.م70.31 The company is up 51% from its price of ج.م46.45 on 28 October 2020. The Egyptian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م82.02 per share. Price Target Changed • Jan 21
Price target raised to ج.م86.93 Up from ج.م81.05, the current price target is an average from 2 analysts. The new target price is 26% above the current share price of ج.م68.87. As of last close, the stock is up 22% over the past year. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment improved over the past week After last week's 15% share price gain to ج.م68.14, the stock is trading at a trailing P/E ratio of 8.3x, up from the previous P/E ratio of 7.2x. This compares to an average P/E of 10x in the Chemicals industry in Egypt. Total return to shareholders over the past three years is a loss of 19%. Major Estimate Revision • Dec 17
Analysts update estimates The 2020 consensus earning per share (EPS) estimate increased from ج.م7.79 to ج.م8.89. Revenue estimate for the same period was approximately flat at ج.م7.74b. Net income is expected to shrink by 4.9% next year compared to 5.8% growth forecast for the Chemicals industry in Egypt . The consensus price target increased from ج.م81.05 to ج.م81.55. Share price is up 1.4% to ج.م57.99 over the past week. Is New 90 Day High Low • Nov 26
New 90-day high: ج.م53.50 The company is up 4.0% from its price of ج.م51.52 on 27 August 2020. The Egyptian market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ج.م49.72 per share.